Accretion Pharmaceuticals Ltd IPO

Accretion Pharmaceuticals Ltd IPO

Pharmaceuticals

sme

Bidding period

14 May 2025 - 16 May 2025

Bid price

₹96.00 - ₹101.00

Listing on

NSE-SME

Listing date

21 May 2025

Lot size

1200 shares

Issue size

₹29.75 crore


Minimum investment

₹1,21,200.00 / 1 lot

Maximum investment

₹1,21,200.00 / 1 lot

Bidding closes in 8 days

INVEST IN IPO
INVEST IN IPO

Accretion Pharmaceuticals Ltd IPO dates

IPO opening date

14 May 2025

IPO end date

16 May 2025

Allotment date

19 May 2025

Initiation of refunds

20 May 2025

Credit of shares to demat

20 May 2025

IPO listing date

21 May 2025

Accretion Pharmaceuticals Ltd IPO financials

Particulars

For the period ending in March 2024 (in ₹ million)

Total assets ₹26.87
Total liabilities ₹26.87
Total expenditure ₹11.41
Total revenue ₹13.41
Profit after tax ₹1.49
EBITDA ₹2.69
Adjusted EBITDA ₹0.00

Accretion Pharmaceuticals Ltd shareholder pattern

Pre-issue Post-issue
Promoter group 0.0 0.0
Public group 0.0 0.0

Accretion Pharmaceuticals Ltd strengths and risks

Information currently unavailable

  • Experienced Promoters and Management Team.

  • Consistently supplying quality products to our valued customers in time.

  • Continually improving the quality standards by implementing process control and prevention techniques.

  • Long-standing relationship with clients and suppliers.

  • Quality standards.

  • Legacy Business Process & Management.

  • Strong and experienced R&D team.

  • We have certain outstanding litigation against us, an adverse outcome of which may adverselyaffect our business, reputation and results of operations.

  • Our Company operates in pharmaceutical sector, which is extensively regulated, any failure onour part to comply with the existing and future statutory and/or regulatory requirements in thepharmaceutical sector could adversely affect our business, results of operations and financialcondition.

  • Our manufacturing units are subject to periodic inspections and audits by regulatory authoritiesand clients. We may be subject to regulatory action which may damage our reputation leadingto an adverse effect on our business, results of operations, financial condition and cash flows.

  • We have a very limited operating history as a Company, which may make it difficult for investorsto evaluate our historical performance or future prospects.

  • We have only one Manufacturing Facility, continued operations of our manufacturing facility iscritical to our business and any disruption in the operation of our manufacturing facility mayhave a material adverse effect on our business, results of operations and financial condition.

  • We generate a significant percentage of our revenue from few clients. The loss of any one or more of our major clients would have a material adverse effect on our business operations and profitability.

  • Our top ten suppliers contribute majority of our purchases. Any loss of business with one or more of them may adversely affect our business operations and profitability.

  • Our business operations are concentrated in the Gujarat, any adverse developments affectingour operations in this region could have a significant impact on our revenue and results ofoperations.

  • We rely on third party providers for carrying out testing of the products manufactured by us.While we do not have direct control over such tests, any occurrence of non-compliance withapplicable regulations, or any errors or omissions during the testing process could adverselyaffect our business, results of operations and financial condition.

  • We do not have long-term agreements with most of our customers and the loss of one or moreof them or a reduction in their demand for our products could adversely affect our business,results of operations, financial condition and cash flows.

How to check the allotment status of the Accretion Pharmaceuticals Ltd IPO?

To check the IPO allotment status, follow these steps:

 

  1. Visit the official website of the IPO’s registrar.
  2. Go to the IPO allotment status page.
  3. Select the ‘Accretion Pharmaceuticals Ltd’ from the list of available IPOs.
  4. Enter your PAN, Demat ID, or application number.
  5. Click on ‘Submit’ or ‘Check Status’ to view your allotment details.

Alternatively, you can also check the allotment status on stock exchange websites such as the NSE or BSE.

To check the IPO allotment status, follow these steps:

 

  1. Visit the official website of the IPO’s registrar.
  2. Go to the IPO allotment status page.
  3. Select the ‘Accretion Pharmaceuticals Ltd’ from the list of available IPOs.
  4. Enter your PAN, Demat ID, or application number.
  5. Click on ‘Submit’ or ‘Check Status’ to view your allotment details.

Alternatively, you can also check the allotment status on stock exchange websites such as the NSE or BSE.

Read more Read less

Accretion Pharmaceuticals Ltd IPO registrar

KFin Techologies Ltd

Phone number +91-40-6716 2222/
E-mail ID apl.ipo@kfintech.com
Website www.kfintech.com

Accretion Pharmaceuticals Ltd IPO reservation

QIB shares offered

0 (0.0%)

NII (HNI) shares offered

0 (0.0%)

Retail shares offered

0 (0.0%)

Anchor investor shares offered

0 (0.0%)

Total shares offered

0

Total shares with anchor investor

0

Accretion Pharmaceuticals Ltd IPO lead manager

  • Jawa Capital Services Pvt Ltd

Explore other IPOs

Aditya Infotech Limited logo
Aditya Infotech Limited logo

Aditya Infotech Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advance Agrolife Limited logo
Advance Agrolife Limited logo

Advance Agrolife Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advanced SysTek Limited logo
Advanced SysTek Limited logo

Advanced SysTek Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Aegis Vopak Terminals Limited logo
Aegis Vopak Terminals Limited logo

Aegis Vopak Terminals Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Agilus Diagnostics Limited logo
Agilus Diagnostics Limited logo

Agilus Diagnostics Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Airox Technologies Limited logo
Airox Technologies Limited logo

Airox Technologies Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ajay Poly Limited logo
Ajay Poly Limited logo

Ajay Poly Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
All Time Plastics Limited logo
All Time Plastics Limited logo

All Time Plastics Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Allchem Lifescience Limited logo
Allchem Lifescience Limited logo

Allchem Lifescience Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Amanta Healthcare Limited logo
Amanta Healthcare Limited logo

Amanta Healthcare Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anand Rathi Share AND Stock Brokers Limited logo
Anand Rathi Share AND Stock Brokers Limited logo

Anand Rathi Share AND Stock Brokers Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anlon Healthcare Limited logo
Anlon Healthcare Limited logo

Anlon Healthcare Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Anthem Biosciences Limited logo
Anthem Biosciences Limited logo

Anthem Biosciences Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
AOne Steels India Limited logo
AOne Steels India Limited logo

AOne Steels India Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ardee Engineering Limited logo
Ardee Engineering Limited logo

Ardee Engineering Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Armee Infotech Limited logo
Armee Infotech Limited logo

Armee Infotech Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Asirvad Microfinance Limited logo
Asirvad Microfinance Limited logo

Asirvad Microfinance Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Atlanta Electricals Limited logo
Atlanta Electricals Limited logo

Atlanta Electricals Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Avanse Financial Services Limited logo
Avanse Financial Services Limited logo

Avanse Financial Services Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

Frequently asked questions

What is the listing date for the Accretion Pharmaceuticals Ltd IPO?

The listing date for the Accretion Pharmaceuticals Ltd IPO is 21 May 2025.

What is the issue size of Accretion Pharmaceuticals Ltd IPO?

The issue size of the Accretion Pharmaceuticals Ltd IPO is ₹29.75 cr.

What is the minimum lot size needed for Accretion Pharmaceuticals Ltd IPO?

The minimum lot size for Accretion Pharmaceuticals Ltd IPO is 1200

When does the Accretion Pharmaceuticals Ltd open and close?

Accretion Pharmaceuticals Ltd IPO is open from 14 May 2025 to 16 May 2025.

How can I apply for the Accretion Pharmaceuticals Ltd IPO?

To apply for the Accretion Pharmaceuticals Ltd, follow the steps given below:

  • Log in to your Bajaj Broking trading account and navigate to the current IPOs section.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen PO.
  • Enter the quantity and your UPI ID. You will receive a mandate notification to block funds in your UPI app.
SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)